Wed May 01 2024
-
“Institutional Review Board (IRB) and the Protocol Review and Monitoring Committee (PRMC) – What’s the Difference?”1:00pm - 1:00pmHSRF room 300
For researchers who intend to recruit cancer patients from cancer-focused clinics, or the primary aim of the study is related to cancer (the diagnosis, screening, treatment, or prevention of cancer; risk factors associated with the development or survivorship of cancer; data and/or biological specimens from cancer patients) this session will review the fundamental differences and regulatory mandates required for each committee’s reviews.
Revised date/time - Wednesday May 1, 20241:00- 2:00 HSRF<https://map.concept3d.com/?id=1194#!m/316672> room 300
Presented by: Melanie Locher, B.S., IRB Director & Christa Varnadoe-Rothman, DNP, MSN, AGNP-C, OCN, CCRP, Director, Cancer Clinical Trials